NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/11/2025
Back to search
Official data from USPTO
OXALOACETATE CFS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OXALOACETATE CFS
ST13
US500000098848748Class
5
Filing
98848748
Registration
8025393
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
11/12/2025
Trademark type
Word
Nice classes
5
Filing date
11/12/2024
Registration date
11/11/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/11/2025
Last transaction
11/12/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
First use anywhere
02/01/2024
First use in commerce
02/01/2024
Drawing code
4
Owner type
16
Owner location
San Diego, CA
Examiner
KHOURI,SANI PHILIPPE
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Terra Biological LLC
Representatives
Rexford Brabson T-Rex Law, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicinal preparations for ME/CFSmyalgic encephalomyelitis/chronic fatigue syndrome; Dietary supplements for ME/CFSmyalgic encephalomyelitis/chronic fatigue syndrome; Food supplements for ME/CFSmyalgic encephalomyelitis/chronic fatigue syndrome
Publications
History of USPTO decisions and trademark events.
19 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
11/11/2025
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
10/15/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/14/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/14/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/14/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/29/2025
GNFR
FINAL REFUSAL E-MAILED
07/29/2025
CNFR
FINAL REFUSAL WRITTEN
07/29/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/12/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/12/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/12/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/14/2025
GNRT
NON-FINAL ACTION E-MAILED
05/14/2025
CNRT
NON-FINAL ACTION WRITTEN
05/14/2025
DOCK
ASSIGNED TO EXAMINER
05/08/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/05/2025
MAFR
APPLICATION FILING RECEIPT MAILED
11/12/2024
NWAP
NEW APPLICATION ENTERED
11/12/2024
Continuous trademark protection
Get notified about every new filing that threatens OXALOACETATE CFS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.